knowledge -WSS

knowledge

author：leisure time 2025-10-02 00:51:58 - browse：87

Illustration of a dollar sign with arrows. — Adobe

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

Centene, for instance, says, it is “investing in artificial intelligence and machine learning technologies to improve the health of our members and contain rising healthcare costs.” The insurer, whose plans cover more than 28 million Americans, noted that its large footprint, particularly in government-sponsored programs, puts it “in a unique position to use data to develop models that predict a wide range of health outcomes.”

A STAT review of regulatory filings from publicly traded health insurers showed that several of them, including Elevance, Molina, and Cigna, are investing in AI with the goal of saving money. Elevance has hired nearly 500 people to work exclusively on AI. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： After a drawn out lobbying fight, ARPA

knowledge

hotspot

WSS

Medicare drug price negotiation program allowed for now

Bird flu in dairy cattle: New measures to control spread to humans

Florida Supreme Court upholds state's abortion ban

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Listen: Who gets the credit for GLP

Would Medicare drug price negotiations stall in a shutdown?

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Pancreatic cancer is often deadly, but new discoveries are raising hope

ChatGPT in medicine: STAT answers readers' burning questions

U.K. decision on ALS drug has neurologists, advocates up in arms

BioMarin wins approval for gene therapy to treat hemophilia A

How one patient went off dialysis — and others can too

Trump demands the U.S. pay no more for drugs than other countries … again

Scientific mystery highlights the blind spots in genomics databases

Apple is now the first public company to be valued at $3 trillion

Inequities make cancer less preventable for women: report

knowledge

Cigna to pay $172 million to settle Medicare Advantage fraud probe

How the Dana

Medicare drug price negotiation program allowed for now

Why do women spend more than men on medical expenses?

Young boy dies in trial for Pfizer Duchenne gene therapy

Listen: Who gets the credit for GLP

focus

knowledge

hotspot

knowledge